http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020000892-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-24069
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-33
filingDate 2019-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e47434594fac08811ec8d554d0f81cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df45eb3939410e27d8f9377f2de37b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56672bb9941c3929e771662f2e0fc4a
publicationDate 2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020000892-A1
titleOfInvention Injection Paradigm For Administration Of Botulinum Toxins
abstract Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033610-B2
priorityDate 2010-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1034930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1034930

Total number of triples: 38.